We reviewed the literature on the efficacy and effectiveness of beta-blocker therapy and examined the economic consequences of under-utilisation. Despite the literature documenting the value of beta-blockers, the therapy is not prescribed at the appropriate rates. Approximately half of acute...

In 2009, the Centers for Medicare & Medicaid Services publicly reported hospital-level risk-standardized 30-day mortality and readmission rates after acute myocardial infarction (AMI) and heart failure (HF). The authors calculated 30-day mortality and readmission rates for all Medicare...

In 2009, the Centers for Medicare & Medicaid Services publicly reported hospital-level risk-standardized 30-day mortality and readmission rates after acute myocardial infarction (AMI) and heart failure (HF). The authors calculated 30-day mortality and readmission rates for all Medicare...